Galapagos NV.
GLPG.US | Research and experimental development on natural sciences and engineering
Galapagos NV is a biotechnology company focused on the discovery and development of novel medicines. The company's primary focus is on developing innovative therapies for diseases with high unmet medical needs, particularly in the areas of inflammation, fibrosis, and other indications. Galapagos uti...Show More
Better Health for All
0
Based on the provided articles, there is insufficient evidence to assess Galapagos NV's alignment with the 'Better Health for All' value. The articles primarily focus on Unilever's environmental practices and do not provide information on Galapagos NV's health impact, pricing strategies, accessibility programs, or other relevant metrics.
1
,
2
,
3
,
4
,
5
,
6
Without specific data on Galapagos NV's pharmaceutical products, clinical trial ethics, or health equity programs, a meaningful assessment cannot be made. The materiality analysis indicates that Galapagos' business model is inherently supportive of the 'Better Health for All' value, but concrete evidence is needed to determine the extent of their contribution. Further research is needed to evaluate the company's performance in this area.
Fair Money & Economic Opportunity
0
Galapagos NV is a biotechnology company focused on drug discovery and development, not financial services.
1
The company's core business does not involve lending, deposit services, or other financial products for consumers.
2
Therefore, all KPIs related to financial inclusion, pricing, fees, lending compliance, wealth building outcomes, and financial literacy are not applicable to its operations.
Fair Pay & Worker Respect
0
No evidence available to assess Galapagos NV on Fair Pay & Worker Respect.
Fair Trade & Ethical Sourcing
0
No evidence available to assess Galapagos NV on Fair Trade & Ethical Sourcing.
Honest & Fair Business
0
No evidence available to assess Galapagos NV on Honest & Fair Business.
Kind to Animals
-40
Galapagos explicitly forbids unethical treatment of animals and adheres to the 'Three Rs' principle (Refinement, Reduction, and Replacement) in preclinical testing.
1
A dedicated Animal Welfare Committee, created in 2019, oversees animal welfare activities, supports scientists, and reports to senior management.
2
The company uses in silico (computer modeling) and in vitro (cellular testing) methods for early assessment of potential safety, genotoxicity, and cardiotoxicity issues.
3
In 2023, the number of animals used in testing decreased.
4
Galapagos is engaged in partnerships, including the Virtual Human Platform, to accelerate the transition to animal-free safety assessments.
5
However, the company has no public position on animal welfare legislation.
No War, No Weapons
-40
Galapagos NV states alignment with the UN Global Compact.
1
The company has a Code of Conduct, established in 2021 and updated at the beginning of 2023, which applies to employees, directors, officers, suppliers, and partners.
2
The Code of Conduct states that acting in a way that conflicts with its principles will have consequences.
3
In 2023, 94% of employees completed the Code of Conduct training, and one breach was escalated to the Audit Committee.
4
In 2022, 97.1% of employees completed the training, and one breach was reported.
5
In 2021, 93.5% of employees completed the training, and one breach was reported.
6
Planet-Friendly Business
0
No evidence available to assess Galapagos NV on Planet-Friendly Business.
Respect for Cultures & Communities
0
Galapagos NV states that FPIC processes are not applicable to its operations as its reports do not discuss projects involving indigenous peoples.
1
The company also reported that 93.5% of employees completed training on the new Code of Conduct in 2021.
2
However, this training is not explicitly defined as cultural sensitivity training, and the rubric specifies 'Standard diversity training without specific cultural sensitivity components' as a score of 0.
Safe & Smart Tech
-30
Galapagos NV has no documented data breaches and states that personal data will not be passed to others without consent, except as legally required or to authorized agents, with no incidents of unauthorized data use reported.
1
The company provides users with rights to access, rectification, erasure, restriction of processing, data portability, objection, and consent withdrawal, with a one-month timeframe to respond to requests.
2
However, the company retains clinical trial related data for 25 years after trial completion, which is a very long retention period.
3
Galapagos confirms compliance with Belgian, European, UK, and relevant US privacy laws and regulations, including GDPR.
4
The company uses the Wordfence Security WordPress plugin to protect its site against malicious attacks, indicating some vulnerability management practices.
5
Zero Waste & Sustainable Products
0
No evidence available to assess Galapagos NV on Zero Waste & Sustainable Products.